Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
80.69
-0.30 (-0.37%)
At close: Nov 7, 2025, 4:00 PM EST
80.71
+0.02 (0.02%)
After-hours: Nov 7, 2025, 6:03 PM EST
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.17 billion as of November 7, 2025. Its market cap has increased by 412.33% in one year.
Market Cap
1.17B
Enterprise Value
1.09B
1-Year Change
412.33%
Ranking
Category
Stock Price
$80.69
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.17B, an increase of 489.61%. That is a compound annual growth rate of 241.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 1.17B | 424.31% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.56B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |